Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published December 15, 2025

StuffbyNainax MR 7 SUPER 700000 Capsules: FDA Finds Undeclared Sildenafil and Tadalafil

FDA analysis shows StuffbyNainax's MR 7 SUPER 700000 capsules contain undeclared sildenafil and tadalafil. Consumers should stop using these capsules immediately as they were marketed without FDA approval.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0397-2026DrugStuffbyNainax ›
Official FDA recall photos · click to enlarge
Take action

Contact the company

Recalling firmStuffbyNainax2830 Lake Rd Apt 1102 · Huntsville, TX 77340-5662
✎ GovInfoNow plain-language explainer

StuffbyNainax is recalling its MR 7 SUPER 700000 capsules because FDA testing found undeclared sildenafil and tadalafil. This means the product was sold without proper FDA approval, which could pose health risks. Read more at govinfonow.com/recall/31616-stuffbynainax-mr-7-super-700000-capsules-fda-finds-undeclared-sildenafil.

Source Summary by GovInfoNow · govinfonow.com/recall/31616-stuffbynainax-mr-7-super-700000-capsules-fda-finds-undeclared-sildenafil · Updated August 17, 2026 · FDA enforcement record: FDA #D-0397-2026

Cite this page

“StuffbyNainax MR 7 SUPER 700000 Capsules: FDA Finds Undeclared Sildenafil and Tadalafil.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31616-stuffbynainax-mr-7-super-700000-capsules-fda-finds-undeclared-sildenafil. Based on FDA recall #D-0397-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0397-2026%22&limit=1).

The FDA announced on Dec. 15, 2025, that StuffbyNainax is recalling MR. 7 SUPER 700000 capsules because they contain undeclared sildenafil and tadalafil. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: StuffbyNainax
  • Product: MR. 7 SUPER 700000 capsules, 1 capsule blister card
  • Distributor: mR. 7
  • Expiration date: Exp 12/31/2029
  • Units affected: 4

The hazard

FDA analysis revealed the presence of undeclared sildenafil and tadalafil in the product, leading to its classification as marketed without an approved New Drug Application or Abbreviated New Drug Application.

Context

GovInfoNow's records show other recent recalls of similar products include Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21) and SILINTAN 25-pill bottle recalled for undeclared meloxicam in FDA analysis (2025-10-20). Shoolin Pharma Chem Sildenafil Recall occurred on 2026-08-03 due to FDA Inspection Findings.

How to tell if you have this one

Check for the product name 'MR 7 SUPER 700000 capsules' with a 1-capsule blister card. The capsules were distributed by mR. 7 and expire on 12/31/2029.

  • Brand
    StuffbyNainax
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Capsules

    Immediately stop using the MR 7 SUPER 700000 capsules as they contain undeclared sildenafil and tadalafil.

How this recall unfolded

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Dec 15, 202512. Published in FDA’s Enforcement Report: Mar 11, 202623. FDA classified it Class I: Mar 18, 2026320252026
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I

Dates from the agency record only; steps without a date are left out.

Similar recalls

Mojo Max Fusion XXX Capsules: Undeclared Sildenafil and Tadalafil Risk
Mohamed HagarMeta Herbal Magnum XXL 9800: Unapproved Sildenafil Risk
Meta HerbalZapMax 500mg Capsules Recall: Undeclared Sildenafil and Diclofenac Risk
ZapMaxShogun-X 7000 Capsule Recall: Unapproved Drugs Found
Nuri Trading LLCAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health Packaging

Latest drug recalls

Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,
Teva Pharmaceuticals · September 29, 2026Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0397-2026 (December 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0397-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA